Research Products

Pli-RCA TB RIF/INH LF

Pli-RCA TB RIF/INH LF is a high-performance nucleic acid test using Rolling Circle Amplification technology for the detection of M. tuberculosis complex (MTBC) and associated drug resistance genes to rifampicin and isoniazid. Our patented mfloDx™ technology using lateral flow is used for amplicon visualization. 

For research use only and NOT intended for in vitro diagnosis.

EMPE TBDx

EMPE TBDx is a high-performance qPCR assay designed for the rapid and accurate detection of Mycobacterium tuberculosis complex (MTBC) from genomic DNA using 3 gene targets.

For research use only and NOT intended for in vitro diagnosis.

EMPE TBDx plus

For the qPCR detection of Mycobacterium tuberculosis complex (MTBC) using 4 gene targets.

For research use only and NOT intended for in vitro diagnosis.

Pli-RCA TB RIF/INH qRCA

For the qRCA detection of Mycobacterium tuberculosis complex (MTBC) & drug resistance genes to rifampicin & isoniazid.

For research use only and NOT intended for in vitro diagnosis.

Pli-RCA TB RIF/INH/FQ qRCA

For the qRCA detection of Mycobacterium tuberculosis complex (MTBC) & drug resistance genes to rifampicin, isoniazid & fluoroquinolones.

For research use only and NOT intended for in vitro diagnosis.

About Us

Founded in 2015, EMPE Diagnostics is a pioneering healthcare company based on innovations from the prestigious Karolinska Institutet in Sweden. We are dedicated to addressing the global TB crisis by developing rapid, reliable, and cost-effective diagnostic solutions. Our mission is to combat TB and AMR by providing tests that not only detect TB disease but also simultaneously profile AMR, ensuring patients receive the correct treatment from the onset.